Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 6 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Fennec Pharmaceuticals Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −1 vs. Q3 2021
- Shares held
- 11.3M
- −300.3K (−2.6%) vs. Q3 2021
- Total value
- $49.9M
- −$59.8M (−54.5%) vs. Q3 2021
- New holders
- 7
- 11 more added
- Sold out
- 8
- 7 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FENC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 105 | $175.1M |
| Q1 2026 | 90 | $99.6M |
| Q4 2025 | 96 | $119.6M |
| Q3 2025 | 84 | $129.8M |
| Q2 2025 | 78 | $112.9M |
| Q1 2025 | 68 | $81.6M |
| Q4 2024 | 64 | $101.4M |
| Q3 2024 | 63 | $74.6M |
| Q2 2024 | 64 | $87.7M |
| Q1 2024 | 65 | $161.1M |
| Q4 2023 | 56 | $168.4M |
| Q3 2023 | 55 | $107.6M |
| Q2 2023 | 56 | $124.5M |
| Q1 2023 | 54 | $108.5M |
| Q4 2022 | 43 | $119.5M |
| Q3 2022 | 31 | $92.1M |
| Q2 2022 | 28 | $63.2M |
| Q1 2022 | 28 | $64.1M |
| Q4 2021 | 30 | $49.9M |
| Q3 2021 | 32 | $109.7M |
| Q2 2021 | 39 | $88.0M |
| Q1 2021 | 53 | $89.3M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Fennec Pharmaceuticals Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 17 | $0 | 0.00% | −77−81.9% | Reduced |
| Toronto Dominion Bank | 54 | $0 | 0.00% | +31+134.8% | Added |
| JPMorgan Chase & Co | 70 | $0 | 0.00% | +70 | New |
| BNP Paribas Arbitrage, SA | 232 | $1.02K | 0.00% | −24−9.4% | Reduced |
| TD Waterhouse Canada Inc. | 555 | $2.50K | 0.00% | +555 | New |
| Simplex Trading, LLC | 899 | $3.00K | 0.00% | +658+273.0% | Added |
| Fortitude Advisory Group L.L.C. | 1,500 | $7.00K | 0.00% | +1,500 | New |
| Ancora Advisors, LLC | 6,000 | $26.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,970 | $26.0K | 0.00% | +5,970 | New |
| UBS Group AG | 7,777 | $34.0K | 0.00% | +7,713+12,051.6% | Added |
| Advisor Group Holdings, Inc. | 10,970 | $48.0K | 0.00% | −1,400−11.3% | Reduced |
| Bank of America Corp | 11,383 | $51.0K | 0.00% | +6,536+134.8% | Added |
| Goldman Sachs Group Inc | 13,448 | $59.0K | 0.00% | +16+0.1% | Added |
| Citadel Advisors LLC | 14,874 | $65.0K | 0.00% | +14,874 | New |
| Geode Capital Management, LLC | 19,619 | $86.0K | 0.00% | −290−1.5% | Reduced |
| Wealthspire Advisors, LLC | 25,000 | $110.0K | 0.00% | +25,000 | New |
| Hartford Financial Management Inc. | 34,848 | $153.0K | 0.04% | +6,000+20.8% | Added |
| Valley Forge Investment Consultants Inc Adv | 40,000 | $176.0K | 0.08% | 00.0% | Unchanged |
| Morgan Stanley | 41,009 | $180.0K | 0.00% | +26+0.1% | Added |
| Tamar Securities, LLC | 53,475 | $235.0K | 0.07% | +53,475 | New |
| BlackRock Inc. | 57,499 | $253.0K | 0.00% | +178+0.3% | Added |
| Susquehanna International Group, LLP | 134,101 | $590.0K | 0.00% | +107,159+397.7% | Added |
| Harbert Fund Advisors, Inc. | 189,750 | $835.0K | 0.39% | +15,000+8.6% | Added |
| Millennium Management LLC | 257,617 | $1.13M | 0.00% | −40.0% | Reduced |
| 683 Capital Management, LLC | 709,300 | $3.12M | 0.15% | −400,700−36.1% | Reduced |
| Solas Capital Management, LLC | 867,857 | $3.82M | 2.72% | 00.0% | Unchanged |
| DG Capital Management, LLC | 1,159,389 | $5.10M | 1.02% | +540,938+87.5% | Added |
| Avoro Capital Advisors LLC | 1,200,000 | $5.28M | 0.09% | −470,000−28.1% | Reduced |
| Sonic Fund II, L.P. | 2,407,357 | $10.6M | 6.86% | 00.0% | Unchanged |
| Southpoint Capital Advisors LP | 4,077,214 | $17.9M | 0.34% | 00.0% | Unchanged |
| Ergoteles LLC | 0 | $0 | 0.00% | −91,434−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −55,935−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −31,728−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −17,790−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −10,994−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −2,648−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| Wealth Quarterback LLC | – | – | – | – | Not filed |